MRC1 and Alzheimer disease: Our findings revealed a significant increase in the fluorescent expression of the M1 subtype (iNOS+) in both the AD and normal groups (Figure 3A), while the fluorescent expression of the M2 subtype (CD206+) exhibited a marked decrease (Figure 3C).